Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Sindan-Pharma SRL
FDA Inspection
•Sindan-Pharma SRL•July 28, 2017

Sindan-Pharma SRL – FDA Inspection, Jul 28, 2017

Record Details

This FDA Inspection record concerns Sindan-Pharma SRL, with an inspection on July 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Sindan-Pharma SRL
Inspection Date
July 28, 2017
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Toyin B. Oladimeji (Company Rep)
View Company Profile

ID · 28d85fc2-099b-45cc-8a29-8c6beb1e56ca

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1019456
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

15
  1. 21 CFR 211.165(d)Acceptance criteria for sampling & testing
  2. 21 CFR 211.46(c)Exhaust systems inadequate to control air contamination
  3. 21 CFR 211.68(b)Computer control of master formula records
  4. 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
  5. 21 CFR 211.167(a)Sterility/pyrogen-free testing
  6. 21 CFR 211.165(b)Microbiological testing
  7. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  8. 21 CFR 211.160(a)Following/documenting laboratory controls
  9. 21 CFR 211.194(a)Complete test data included in records
  10. 21 CFR 211.113(b)Procedures for sterile drug products

Showing 10 of 15 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Sindan-Pharma SRL

6
DateClassificationOfficeProject area
August 2, 2024NAICenter for Drug Evaluation and ResearchBioresearch Monitoring
March 16, 2023Not classifiedOffice of Inspections and Investigations
April 5, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
June 15, 2015NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 10, 2013NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Sindan-Pharma SRL
  • FDA Inspection 1247794 - 2024-08-02
  • FDA Inspection 1244074 - 2023-03-16
  • FDA Inspection 1137635 - 2018-04-05
  • FDA Inspection 933708 - 2015-06-15
  • FDA Inspection 874880 - 2013-12-10

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sindan-Pharma SRL
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.